Trade OPKO Health, Inc. - OPK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0180 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023568% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001346% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.646 |
| Open | 1.626 |
| 1-Year Change | 20.85% |
| Day's Range | 1.566 - 1.626 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 3, 2025 | 1.5660 | -0.0400 | -2.49% | 1.6060 | 1.6260 | 1.5560 |
| Apr 2, 2025 | 1.6460 | 0.0100 | 0.61% | 1.6360 | 1.6660 | 1.5960 |
| Apr 1, 2025 | 1.6560 | -0.0100 | -0.60% | 1.6660 | 1.6760 | 1.6360 |
| Mar 31, 2025 | 1.6560 | -0.0100 | -0.60% | 1.6660 | 1.6760 | 1.6360 |
| Mar 28, 2025 | 1.6960 | -0.0100 | -0.59% | 1.7060 | 1.7360 | 1.6760 |
| Mar 27, 2025 | 1.7260 | -0.0400 | -2.27% | 1.7660 | 1.7860 | 1.7260 |
| Mar 26, 2025 | 1.7660 | 0.0000 | 0.00% | 1.7660 | 1.7760 | 1.7560 |
| Mar 25, 2025 | 1.7960 | 0.0100 | 0.56% | 1.7860 | 1.7960 | 1.7660 |
| Mar 24, 2025 | 1.7960 | 0.0200 | 1.13% | 1.7760 | 1.8160 | 1.7760 |
| Mar 21, 2025 | 1.7860 | 0.0100 | 0.56% | 1.7760 | 1.7960 | 1.7460 |
| Mar 20, 2025 | 1.8060 | 0.0300 | 1.69% | 1.7760 | 1.8460 | 1.7760 |
| Mar 19, 2025 | 1.8560 | 0.1000 | 5.69% | 1.7560 | 1.8560 | 1.7360 |
| Mar 18, 2025 | 1.7660 | -0.0200 | -1.12% | 1.7860 | 1.8060 | 1.7460 |
| Mar 17, 2025 | 1.7960 | 0.0600 | 3.46% | 1.7360 | 1.8060 | 1.7160 |
| Mar 14, 2025 | 1.7260 | 0.0200 | 1.17% | 1.7060 | 1.7260 | 1.6960 |
| Mar 13, 2025 | 1.7160 | 0.0000 | 0.00% | 1.7160 | 1.7560 | 1.7160 |
| Mar 12, 2025 | 1.7660 | -0.0300 | -1.67% | 1.7960 | 1.8060 | 1.7460 |
| Mar 11, 2025 | 1.7860 | -0.1400 | -7.27% | 1.9260 | 1.9360 | 1.7660 |
| Mar 10, 2025 | 1.8360 | -0.0200 | -1.08% | 1.8560 | 1.9060 | 1.8260 |
| Mar 7, 2025 | 1.8960 | 0.0700 | 3.83% | 1.8260 | 1.9260 | 1.8260 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
OPKO Health, Inc. Company profile
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company''s Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.| Industry: | Medical & Diagnostic Laboratories |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com